English Spanish Chinese Russian German French Japanese Hindi Telugu Tamil

Translational Biomedicine

  • ISSN: 2172-0479
  • Índice h do diário: 16
  • Pontuação de citação de diário: 5.91
  • Fator de impacto do periódico: 3.66
Indexado em
  • Abra o Portão J
  • Genamics JournalSeek
  • JournalTOCs
  • Bíblia de pesquisa
  • O Fator de Impacto Global (GIF)
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • Scimago
  • Biblioteca de periódicos eletrônicos
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • OCLC- WorldCat
  • Invocação Proquest
  • publons
  • MIAR
  • Comissão de Bolsas Universitárias
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
  • ResearchGate
Veja mais
Compartilhe esta página

Abstrato

The Erythropoietin Effect on Uterus Congestion after Uterine Ischemia Reperfusion

Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G and Papalois A

Objective: This experiment investigated the erythropoietin (Epo) effect after uterine ischemiareperfusion (IR) in rats. The effect of Epo was evaluated studying the mean uterine congestion (UC) lesions. Materials and methods: The mean weight of 40 rats used in the study was 247.7 g. The UC lesions were estimated for the groups A and C on 60 min and for the groups B and D on 120 min after reperfusion. Only the groups C and D were administered by Epo.

Results: Epo administration non-significantly declined the UC lesions scores by (without lesions) 0.15 (-0.5595137-0.2595137) (p=0.4545). Reperfusion time non-significantly raised the UC lesions scores by (without lesions) 0.15 (-0.5676974-0.3676974) (P=0.5058). However, the combined Epo administration with reperfusion time non-significantly declined the UC lesions scores by (without lesions) 0.0090909 (-0.2577992-0.2396174) (p=0.9414).

Conclusions: The Epo administration presented a nonsignificantly declining short-term effect on UC lesions scores. Perhaps, a higher Epo dosage and/or an experimental time lasting longer than 2 hours may reveal more significant efficacies.